Peter Heining
Novartis (Switzerland)(CH)Novartis Institutes for BioMedical Research
Publications by Year
Research Areas
Sphingolipid Metabolism and Signaling, Animal testing and alternatives, Carbohydrate Chemistry and Synthesis, Monoclonal and Polyclonal Antibodies Research, 3D Printing in Biomedical Research
Most-Cited Works
- → Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis(2010)1,242 cited
- → Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator(2013)165 cited
- → Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis(2014)154 cited
- → Physiologically Based Pharmacokinetic Modeling of FTY720 (2-Amino-2[2-(-4-octylphenyl)ethyl]propane-1,3-diol hydrochloride) in Rats After Oral and Intravenous Doses(2006)132 cited
- → Cardiac troponins and creatine kinase content of striated muscle in common laboratory animals(2001)74 cited
- → Comparison of clinical pathology parameters with two different blood sampling techniques in rats: retrobulbar plexus versus sublingual vein(2000)46 cited
- → The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry(2016)42 cited
- → The Use of Minipig in Drug Discovery and Development(2015)34 cited
- → Pharmacokinetics and Cell Trafficking Dynamics of 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol Hydrochloride (FTY720) in Cynomolgus Monkeys after Single Oral and Intravenous Doses(2002)31 cited
- → Vehicle Systems and Excipients Used in Minipig Drug Development Studies(2015)19 cited